Alpha Tau reports 100% disease control in pancreatic cancer trials

Go back to Alpha Tau reports 100% disease control in pancreatic cancer trials
(NASDAQ: DRTS) Delayed: 13.24 --0 (-0%)
Previous Close $13.24    52 Week High
Open $13.24    52 Week Low
Day High $13.24    P/E N/A 
Day Low $13.24    EPS
Volume 95,488       

(NASDAQ: DRTSW) Delayed: 3.54 --0 (-0%)
Previous Close $3.54    52 Week High
Open $3.54    52 Week Low
Day High $3.54    P/E N/A 
Day Low $3.54    EPS
Volume 95,488